恩曲他滨新型抗HIV药物 药理作用 药代动力学 适应证 不良反应 注意事项中文名称:恩曲他滨中文同义词:恩曲他滨;5-氟-1-(2R,5S)-[2-羟甲基-1,3-氧硫环-5-酰]胞嘧啶;依曲西他滨;恩曲他滨 企标 98.0+%;盐酸恩曲他滨;恩曲他滨 EMTRIVA;恩曲他滨 EMTRICITABINE;恩去他滨英文名称:Emtricitabine英文同义词:SM-Q;4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-(2r-cis)-2(1h)-pyrimidinone;(-)-BETA-2',3'-DIDEOXY-5-FLUORO-3'-THIACYTIDINE;EMTRICITABINE;EMTRITABINE;FTC;FUMITREMORGIN C;EMTRICITABINCAS号:143491-57-0分子式:C8H10FN3O3S分子量:247.25EINECS号:相关类别:Intermediates & Fine Chemicals;Pharmaceuticals;Carbohydrates & Derivatives;Chiral Reagents;Heterocycles;Sulfur & Selenium Compounds;信号转导通路激酶抑制剂;医药中间体;微生物Microbiology;抗病毒药物;中间体;Inhibitors;小分子抑制剂，天然产物;医药原料;抗病毒抗感染类Mol文件:143491-57-0.mol恩曲他滨 性质熔点 136-140°C储存条件 -20°C FreezerCAS 数据库143491-57-0(CAS DataBase Reference)

名称：2,6-二羟基蒽醌 别名：2,6-Dihydroxyanthracene-9,10-dione; 2,6-Dihydroxyanthraquinone; anthraflavic acid; anthraflavin; anthraflaric acid; anthrafravic acid; 2,6-dihydroxy-anthraquinon; 2,7 dihydroxyanthraquinone; anthraquinone, 2,6-dihydroxy- CAS号：84-60-6 分子式：C14H8O4 分子量：240.21

名称：5-氨基-2-(三氟甲基)吡啶别名：5-amino-2-trifluoromethyl pyridine; 6-(trifluoromethyl)pyridin-3-amine; 5-Amino-2-(trifluoromethyl)pyridineCAS号：106877-33-2分子式：C6H5F3N2分子量：162.11

名称：2-三氟甲基-5-溴吡啶别名：5-bromo-2-(trifluoromethyl) pyridine; 5-Bromo-2-(trifluoromethyl)pyridine; 5-bromo-2-trifluoromethyl pyridine; 2-Trifluoromethyl-5-bromopyridine; 5-Bromo-2-trifluoromethylpyridine; 5-bromo-2-trifluoromethyl-pyridine; (6-(trifluoro-methyl)pyridin-3-yl)-bromide; 3-bromo-6-(trifluoromethyl)pyridine; 2-trifluoromethyl-5-bromo pyridineCAS号：436799-32-5分子式：C6H3BrF3N分子量：225.99

名称：4-溴-1-甲氧基-2-(3-甲氧基丙氧基)-苯别名：4-Bromo-1-methoxy-2-(3-methoxy-propoxy)-benzene; benzene, 4-bromo-1-methoxy-2-(3-methoxypropoxy)-; 4-Bromo-1-methoxy-2-(3-methoxypropoxy)benzeneCAS号：173336-76-0分子式：C11H15BrO3分子量：275.14

名称：tert-Butyl 5-amino-1H-indazole-1-carboxylate别名：1-BOC-5-AMINO-INDAZOLE; N-(1)-BOC-5-AMINO-INDAZOLE; 5-AMINO-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER; 5-AMINO-1H-INDAZOLE-1-CARBOXYLIC ACID, 1,1 DIMETHYL ETHYL ESTER; tert-butyl 5-amino-1H-indazole-1-carboxylate; 1-boc-5-amino-1h-indazole; 5-amino-1h-indazole, n1-boc protectedCAS号：129488-10-4分子式：C12H15N3O2分子量：233.27

AHU-377药理作用 诺华心血管新药LCZ696 市场分析  新闻专题中文名称:AHU-377中文同义词:4-(((2S,4R)-1-([1,1'-联苯]-4-基)-5-乙氧基-4-甲基-5-氧代戊烷-2-基)氨基)-4-氧代丁酸;LCZ696中间体(AHU-377);AHU-377(LCZ696中间体);(2R,4S)-5-(联苯-4-基)-4-[(3-羧基丙酰基)氨基]-2-甲基戊酸乙酯;(2R,4S)-5-(联苯基-4-基)-4-[(3-羧基丙酰基)氨基]-2-甲基戊酸;原研900-04;沙库必曲;LCZ696中间体5英文名称:AHU-377英文同义词:AHU-377;4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-Methyl-5-oxopentan-2-yl)aMino)-4-oxobutanoic acid;4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-Methyl-5-oxopentan-2-yl)aMino)-4-oxobutanoic acid;(2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester;(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid;4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid;4-{[(2S,4R)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentanyl]amino}-4-oxobutanoic acid;AHU-77CAS号:149709-62-6分子式:C24H29NO5分子量:411.49EINECS号:相关类别:LCZ696;intermediates;Sacubitril;LCZ 696;LCZ696 中间体，AHU-377;LCZ696中间体;杂质对照品;小分子抑制剂Mol文件:149709-62-6.mol

名称：反式-4-(三氟甲基)环己醇别名：trans-4-(Trifluoromethyl)cyclohexanol; Cyclohexanol,4-(trifluoromethyl)-, trans-; trans (e,e)-4-trifluoromethylcyclohexanol; trans-4-trifluoromethylcyclohexanolCAS号：75091-93-9分子式：C7H11F3O分子量：168.16

CAS号:330786-24-8分子式:C17H13N5O分子量:303.31802EINECS号:1592732-453-0相关类别:依鲁替尼中间体;医药中间体;中间体;Ibrutinib;AnticancerMol文件:330786-24-8.mol

名称：5-溴-2-氯苯甲酸别名：Tetrazol-1-acetic acid; Tetrazol-1-ylacetic acid; 5-Bromo-2-chlorobenzoic acid; Benzoic acid, 5-bromo-2-chloro-; BCBA; 2-chloropyridine-4-carbonitrile; 5-bromo-2-chlorobenzoate; 2-Chloro-5-bromobenzoic acid; 5-Bromo-2-chloro-benzoic acid; 5-Bromo-2-chloro benzoic acidCAS号：21739-92-4分子式：C7H4BrClO2分子量：235.46